| Trial ID: | L6429 |
| Source ID: | NCT01999361
|
| Associated Drug: |
Myfortic
|
| Title: |
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
|
| Acronym: |
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes Mellitus
|
| Interventions: |
DRUG: Myfortic
|
| Outcome Measures: |
Primary: allosensitization after complete islet graft loss, Allosensitization after complete islet graft loss after completion of two years of Myfortic® maintenance monotherapy., 3 years |
|
| Sponsor/Collaborators: |
Sponsor: Rodolfo Alejandro
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
18
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2009-01
|
| Completion Date: |
2028-12
|
| Results First Posted: |
|
| Last Update Posted: |
2025-01-27
|
| Locations: |
Diabetes Research Institute, Miami, Florida, 33136, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01999361
|
